174 related articles for article (PubMed ID: 21843643)
41. The bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.
Shukla S; Bafna K; Sundar D; Thorat SS
PLoS One; 2014; 9(6):e90637. PubMed ID: 24603686
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
Ferrera P; Arias C
Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
[TBL] [Abstract][Full Text] [Related]
43. NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2.
Liu G; Ma WY; Bode AM; Zhang Y; Dong Z
J Biol Chem; 2003 Jan; 278(4):2124-30. PubMed ID: 12433932
[TBL] [Abstract][Full Text] [Related]
44. Systematic pharmacological approach to the characterization of NSAIDs.
Lora M; Denault JB; Leduc R; de Brum-Fernandes AJ
Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):55-62. PubMed ID: 9758208
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS
Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086
[TBL] [Abstract][Full Text] [Related]
46. Accelerative effect of a selective cyclooxygenase-2 inhibitor on Fas-mediated apoptosis in human neutrophils.
Iwase M; Takaoka S; Uchida M; Kondo G; Watanabe H; Ohashi M; Nagumo M
Int Immunopharmacol; 2006 Mar; 6(3):334-41. PubMed ID: 16428068
[TBL] [Abstract][Full Text] [Related]
47. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
48. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
49. Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior.
Furse KE; Pratt DA; Porter NA; Lybrand TP
Biochemistry; 2006 Mar; 45(10):3189-205. PubMed ID: 16519514
[TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
[TBL] [Abstract][Full Text] [Related]
51. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
[TBL] [Abstract][Full Text] [Related]
52. New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: Design, synthesis and structure-activity relationship.
Ugwu DI; Okoro UC; Ahmad H
PLoS One; 2017; 12(9):e0183807. PubMed ID: 28922386
[TBL] [Abstract][Full Text] [Related]
53. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
54. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist-induced contractions of the pig isolated ureter.
Mastrangelo D; Wisard M; Rohner S; Leisinger H; Iselin CE
Urol Res; 2000 Dec; 28(6):376-82. PubMed ID: 11221916
[TBL] [Abstract][Full Text] [Related]
55. Induced microsomal PGE synthase-1 is involved in cyclooxygenase-2-dependent PGE2 production in gastric fibroblasts.
Shinji Y; Tsukui T; Tatsuguchi A; Shinoki K; Kusunoki M; Suzuki K; Hiratsuka T; Wada K; Futagami S; Miyake K; Gudis K; Sakamoto C
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G308-15. PubMed ID: 15458923
[TBL] [Abstract][Full Text] [Related]
56. Involvement of cyclooxygenase 2 (COX-2) in intrinsic tone of isolated guinea pig trachea.
Charette L; Misquitta C; Guay J; Reindeau D; Jones TR
Can J Physiol Pharmacol; 1995 Nov; 73(11):1561-7. PubMed ID: 8789408
[TBL] [Abstract][Full Text] [Related]
57. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Pang L; Nie M; Corbett L; Knox AJ
J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
[TBL] [Abstract][Full Text] [Related]
58. Role of Tyr348 in Tyr385 radical dynamics and cyclooxygenase inhibitor interactions in prostaglandin H synthase-2.
Rogge CE; Ho B; Liu W; Kulmacz RJ; Tsai AL
Biochemistry; 2006 Jan; 45(2):523-32. PubMed ID: 16401081
[TBL] [Abstract][Full Text] [Related]
59. Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2.
Miyataka M; Rich KA; Ingram M; Yamamoto T; Bing RJ
Hypertension; 2002 Mar; 39(3):785-9. PubMed ID: 11897764
[TBL] [Abstract][Full Text] [Related]
60. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells.
Smartt HJ; Elder DJ; Hicks DJ; Williams NA; Paraskeva C
Br J Cancer; 2003 Oct; 89(7):1358-65. PubMed ID: 14520472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
